GlycoMimetics Inc (GLYC)
1.80
-0.12
(-6.49%)
USD |
NASDAQ |
Apr 22, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
GlycoMimetics Price to Book Value: 3.02 for April 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 22, 2024 | 3.02 |
| April 19, 2024 | 3.230 |
| April 18, 2024 | 3.624 |
| April 17, 2024 | 3.825 |
| April 16, 2024 | 3.607 |
| April 15, 2024 | 3.783 |
| April 12, 2024 | 4.027 |
| April 11, 2024 | 4.203 |
| April 10, 2024 | 4.110 |
| April 09, 2024 | 4.496 |
| April 08, 2024 | 4.345 |
| April 05, 2024 | 4.614 |
| April 04, 2024 | 4.547 |
| April 03, 2024 | 4.639 |
| April 02, 2024 | 4.966 |
| April 01, 2024 | 5.100 |
| March 28, 2024 | 5.033 |
| March 27, 2024 | 5.335 |
| March 26, 2024 | 4.782 |
| March 25, 2024 | 4.731 |
| March 22, 2024 | 4.916 |
| March 21, 2024 | 4.832 |
| March 20, 2024 | 5.117 |
| March 19, 2024 | 4.916 |
| March 18, 2024 | 4.698 |
| Date | Value |
|---|---|
| March 15, 2024 | 4.295 |
| March 14, 2024 | 4.375 |
| March 13, 2024 | 4.274 |
| March 12, 2024 | 4.392 |
| March 11, 2024 | 4.291 |
| March 08, 2024 | 4.576 |
| March 07, 2024 | 4.694 |
| March 06, 2024 | 4.861 |
| March 05, 2024 | 4.861 |
| March 04, 2024 | 5.096 |
| March 01, 2024 | 5.046 |
| February 29, 2024 | 4.844 |
| February 28, 2024 | 4.811 |
| February 27, 2024 | 5.062 |
| February 26, 2024 | 5.129 |
| February 23, 2024 | 4.861 |
| February 22, 2024 | 4.912 |
| February 21, 2024 | 5.012 |
| February 20, 2024 | 5.582 |
| February 16, 2024 | 5.398 |
| February 15, 2024 | 5.180 |
| February 14, 2024 | 5.163 |
| February 13, 2024 | 5.180 |
| February 12, 2024 | 5.213 |
| February 09, 2024 | 5.515 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Jun 16 2022
5.850
Maximum
Jan 23 2024
1.594
Average
1.228
Median
Aug 11 2020
Price to Book Value Benchmarks
| Altimmune Inc | 2.730 |
| Cellectar Biosciences Inc | -- |
| PDS Biotechnology Corp | 4.197 |
| Syros Pharmaceuticals Inc | 7.922 |
| Precision BioSciences Inc | 3.550 |
Price to Book Value Related Metrics
| Price | 1.80 |
| Earnings Yield | -32.22% |
| Market Cap | 116.01M |